SYNH - Mergers and acquisitions

MORRISVILLE, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company. Together, Syneos Health and RxDataScience will offer biopharma customers technology-enabled, insights-powered solutions with the aim of accelerating performance across the product lifecycle – from lab to life. RxDataScience's scalable platform enables biopharma companies to transform vast volumes of data into strategic, actionable insights. Multidisciplinary teams of product managers, d

MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a leading technology-enabled clinical trial recruitment and retention company. Accelerating product development by better connecting patients, sites and communities, the acquisition boosts Syneos Health's ability to deliver technology-enabled, insight-powered solutions. Customer benefits include accelerated patient enrollment and retention, extensive patient population-based insights, improved site, sponsor and physician experiences and reduced patient burden. Launched in 2014 as a global ne